PFA

Corporate Actions View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+2.3%Reaction day

₹0.44

prior close

₹0.45

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+2.9%-0.6% vs market

Other Financial Services peers, median of 79sector+1.1%+1.2% vs sector

On the reaction day the stock moved 0.6 pts less than Nifty Microcap 250 and 1.2 pts more than its Other Financial Services peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.0

10m

+0.0

15m

+0.0

30m

+0.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+2.3+2.9-0.6+1.1+1.2

Next day

+2.3+5.3-3.1+1.5+0.8

+2.3+2.4-0.1-0.6+2.9

+0.0-0.6+0.6-3.5+3.5

+18.2+4.0+14.2+1.1+17.1

+11.4+4.7+6.7+2.7+8.7

+4.5+6.1-1.6+5.1-0.5

15d

+0.0+17.8-17.8+13.3-13.3

-4.5+18.6-23.1+14.2-18.8

-18.2+24.3-42.5+12.1-30.2

-22.7+32.1-54.8+11.5-34.2

UpDownMarket · Nifty Microcap 250Sector · Other Financial Services peers, median of 79Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Biogen Pharmachem Industries' board, meeting on 23 March 2026, has recommended a bonus issue of 1 fully paid-up equity share for every 6 shares held (1:6 ratio). Approximately 15.04 crore bonus shares of Re. 1 each will be issued, funded from the Securities Premium of around Rs. 17 crore available as on 31 March 2025. Post-issue paid-up capital will rise from Rs. 90.26 crore to about Rs. 105.30 crore. The board also approved increasing authorized share capital from Rs. 91 crore to Rs. 108 crore, and appointed M/s. Goenka Mehta & Associates as new statutory auditors to fill a casual vacancy caused by the medical resignation of the previous auditor. All these items are subject to shareholder approval via postal ballot, with the record date to be announced later.

Likely market impact

The 1:6 bonus issue is a modest capitalisation that will increase share count by about 16.7% and proportionally adjust the share price, but does not change the company's overall value. The auditor change due to medical reasons is routine and should not materially affect shareholders. The stock may see short-term trading interest around the record date announcement.